NCT04687267View on ClinicalTrials.gov

Conservative Management of CIN2 Lesions and Biomarkers Evaluation

CompletedOBSERVATIONAL
Enrollment

319

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2022

Conditions
CIN2
Trial Locations (4)

Unknown

Azienda ULSS 6 Euganea, Padua

Azienda ULSS 2 Marca Trevigiana, Treviso

Azienda ULSS 3 Serenissima, Mestre

Azienda ULSS 9 Scaligera, Verona

All Listed Sponsors
collaborator

Azienda ULSS 3 Serenissima

OTHER

collaborator

Azienda Ulss 6 Euganea

OTHER

collaborator

Azienda Ulss 2 Marca Trevigiana

OTHER

collaborator

Azienda Ulss 9 Scaligera

OTHER_GOV

collaborator

Regione Veneto

OTHER

lead

Istituto Oncologico Veneto IRCCS

OTHER

NCT04687267 - Conservative Management of CIN2 Lesions and Biomarkers Evaluation | Biotech Hunter | Biotech Hunter